Cargando…
Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion
BACKGROUND: Metformin, a widely used hypoglycemic drug, reduces stroke incidence and alleviates chronic inflammation in clinical trials. However, the effect of metformin in ischemic stroke is unclear. Here, we investigated the effect of metformin on ischemic stroke in mice and further explored the p...
Autores principales: | Liu, Yanqun, Tang, Guanghui, Li, Yaning, Wang, Yang, Chen, Xiaoyan, Gu, Xiang, Zhang, Zhijun, Wang, Yongting, Yang, Guo-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201919/ https://www.ncbi.nlm.nih.gov/pubmed/25315906 http://dx.doi.org/10.1186/s12974-014-0177-4 |
Ejemplares similares
-
Netrin-1 attenuates brain injury after middle cerebral artery occlusion via downregulation of astrocyte activation in mice
por: He, Xiaosong, et al.
Publicado: (2018) -
Macrophage depletion reduced brain injury following middle cerebral artery occlusion in mice
por: Ma, Yuanyuan, et al.
Publicado: (2016) -
DL-3n-Butylphthalide Improves Blood–Brain Barrier Integrity in Rat After Middle Cerebral Artery Occlusion
por: Mamtilahun, Muyassar, et al.
Publicado: (2021) -
Mesenchymal Stem Cells Attenuated Blood-Brain Barrier Disruption via Downregulation of Aquaporin-4 Expression in EAE Mice
por: Liu, Yanqun, et al.
Publicado: (2020) -
A new nitronyl nitroxide radical with salicylic acid framework attenuates blood–brain barrier disruption and oxidative stress in a rat model of middle cerebral artery occlusion
por: Chen, Lei, et al.
Publicado: (2022)